Guatemala vs Laos: Cause of death, by non-communicable diseases, ages 5-14
Guatemala
32.2%
in 2021
Laos
33.4%
in 2021
Guatemala rank
108th
Laos rank
106th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Guatemala
- Laos
How they compare
Laos currently reports 33.4% against 32.2% in Guatemala, a difference of 1.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Guatemala ahead.
Guatemala ranks 108th and Laos ranks 106th of 185 countries.
Across the 3 decades both report, Guatemala averaged higher in 2 and Laos in 1.
Head to head by decade
| Decade | Guatemala | Laos | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 24.3% | 21.0% | 3.3% | Guatemala |
| 2010s | 32.8% | 29.6% | 3.2% | Guatemala |
| 2020s | 32.9% | 33.0% | 0.2% | Laos |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Guatemala or Laos?
- Laos, at 33.4% against 32.2% in Guatemala as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Guatemala and Laos?
- 1.2%, with Laos ahead.
- How many years of comparable data are there for Guatemala and Laos?
- 6 years are reported by both, from 2000 to 2021.
- How do Guatemala and Laos rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Guatemala ranks 108th and Laos ranks 106th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.